Porton Pharma Solutions Ltd. (SHE:300363)
China
· Delayed Price · Currency is CNY 14.96
+0.29 (1.98%)
Apr 28, 2025, 2:45 PM CST
Porton Pharma Solutions Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 3,135 | 3,012 | 3,658 | 7,008 | 3,074 | 2,068 | Upgrade
|
| Other Revenue | - | - | 9.44 | 26.99 | 31.17 | 4.05 | Upgrade
|
| Revenue | 3,135 | 3,012 | 3,667 | 7,035 | 3,105 | 2,072 | Upgrade
|
| Revenue Growth (YoY) | 5.66% | -17.87% | -47.87% | 126.55% | 49.87% | 33.56% | Upgrade
|
| Cost of Revenue | 2,291 | 2,271 | 2,230 | 3,398 | 1,843 | 1,237 | Upgrade
|
| Gross Profit | 844.19 | 740.61 | 1,437 | 3,636 | 1,262 | 834.99 | Upgrade
|
| Selling, General & Admin | 528.34 | 557.81 | 693.17 | 807.66 | 386.63 | 303.65 | Upgrade
|
| Research & Development | 326.96 | 338.49 | 452.23 | 519.51 | 262.02 | 155.19 | Upgrade
|
| Other Operating Expenses | -11.59 | -11.7 | 35.09 | 58.54 | 14.06 | 5.68 | Upgrade
|
| Operating Expenses | 843.71 | 884.6 | 1,145 | 1,419 | 706.17 | 468.3 | Upgrade
|
| Operating Income | 0.48 | -143.99 | 291.88 | 2,218 | 555.88 | 366.69 | Upgrade
|
| Interest Expense | - | - | -44.15 | -27.73 | -21.7 | -24.39 | Upgrade
|
| Interest & Investment Income | - | - | 57.88 | 22.83 | 14.31 | 33.17 | Upgrade
|
| Earnings From Equity Investments | -7.2 | -13.62 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -20.01 | 50.25 | 10.79 | -39.77 | Upgrade
|
| Other Non Operating Income (Expenses) | -90.63 | -80.45 | -2.53 | -6.73 | -1.5 | -1.3 | Upgrade
|
| EBT Excluding Unusual Items | -97.35 | -238.06 | 283.07 | 2,256 | 557.77 | 334.4 | Upgrade
|
| Impairment of Goodwill | - | - | -40.64 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -2.5 | -1.78 | -1.63 | -8.18 | -6.79 | 4.14 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.06 | -0.77 | 0.54 | 0.1 | -3.21 | 0.03 | Upgrade
|
| Asset Writedown | -133.66 | -133.43 | -17.49 | -18.63 | -16.22 | -7.07 | Upgrade
|
| Other Unusual Items | - | - | 22.71 | 16.28 | 17.28 | 32.24 | Upgrade
|
| Pretax Income | -234.57 | -374.05 | 246.56 | 2,246 | 548.83 | 363.74 | Upgrade
|
| Income Tax Expense | 32.62 | -8.06 | 71.05 | 309.38 | 73.24 | 40.55 | Upgrade
|
| Earnings From Continuing Operations | -267.19 | -365.99 | 175.52 | 1,936 | 475.59 | 323.19 | Upgrade
|
| Minority Interest in Earnings | 70.02 | 78.24 | 91.34 | 68.99 | 48.33 | 1.22 | Upgrade
|
| Net Income | -197.17 | -287.75 | 266.86 | 2,005 | 523.92 | 324.42 | Upgrade
|
| Net Income to Common | -197.17 | -287.75 | 266.86 | 2,005 | 523.92 | 324.42 | Upgrade
|
| Net Income Growth | - | - | -86.69% | 282.78% | 61.49% | 74.84% | Upgrade
|
| Shares Outstanding (Basic) | 511 | 543 | 545 | 542 | 540 | 532 | Upgrade
|
| Shares Outstanding (Diluted) | 511 | 543 | 545 | 543 | 540 | 541 | Upgrade
|
| Shares Change (YoY) | -6.90% | -0.31% | 0.21% | 0.62% | -0.11% | 1.99% | Upgrade
|
| EPS (Basic) | -0.39 | -0.53 | 0.49 | 3.70 | 0.97 | 0.61 | Upgrade
|
| EPS (Diluted) | -0.39 | -0.53 | 0.49 | 3.69 | 0.97 | 0.60 | Upgrade
|
| EPS Growth | - | - | -86.72% | 280.41% | 61.67% | 71.43% | Upgrade
|
| Free Cash Flow | -10.19 | -85.06 | -500.81 | 1,391 | -296.8 | 110.4 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.16 | -0.92 | 2.56 | -0.55 | 0.20 | Upgrade
|
| Dividend Per Share | - | - | 0.487 | 1.106 | 0.193 | 0.121 | Upgrade
|
| Dividend Growth | - | - | -55.97% | 473.06% | 59.50% | 16.35% | Upgrade
|
| Gross Margin | 26.92% | 24.59% | 39.19% | 51.69% | 40.64% | 40.30% | Upgrade
|
| Operating Margin | 0.01% | -4.78% | 7.96% | 31.52% | 17.90% | 17.70% | Upgrade
|
| Profit Margin | -6.29% | -9.55% | 7.28% | 28.51% | 16.87% | 15.66% | Upgrade
|
| Free Cash Flow Margin | -0.33% | -2.82% | -13.66% | 19.78% | -9.56% | 5.33% | Upgrade
|
| EBITDA | 337.07 | 181.81 | 574.52 | 2,452 | 719.86 | 497.81 | Upgrade
|
| EBITDA Margin | 10.75% | 6.04% | 15.67% | 34.86% | 23.18% | 24.03% | Upgrade
|
| D&A For EBITDA | 336.59 | 325.8 | 282.64 | 234.54 | 163.98 | 131.12 | Upgrade
|
| EBIT | 0.48 | -143.99 | 291.88 | 2,218 | 555.88 | 366.69 | Upgrade
|
| EBIT Margin | 0.01% | -4.78% | 7.96% | 31.52% | 17.90% | 17.70% | Upgrade
|
| Effective Tax Rate | - | - | 28.81% | 13.78% | 13.35% | 11.15% | Upgrade
|
| Revenue as Reported | - | - | 3,667 | 7,035 | 3,105 | 2,072 | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.